Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
103 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
Children's Tumor Foundation Europe from Sint-Joost-ten-Node, company number BE0711985938, closed financial year 2024 with a result of € -25,611 after tax. For that financial year Children's Tumor Foundation Europe recorded a gross margin of € -17,982 and equity of € 58,474. Compared with financial year 2023, the result moved from € 70 to € -25,611. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2025.
€ 58,474
▼ 30% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -25,611
▼ still € 70 profit in 2023
Profit after tax over the fiscal year.
€ 96,614
▼ 29% vs 2023
Cash and bank balances on the last day of the fiscal year.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 1,305
▼ 95% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 4,311
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 42,711 | € 16,714 | € 7,817 | € -17,982 | ▼ € 25,799 |
| Profit after taxes | € 35,225 | € 10,149 | € 70 | € -25,611 | ▼ € 25,681 |
| Equity | € 73,867 | € 84,016 | € 84,085 | € 58,474 | ▼ 30% |
| Total debts | € 280,376 | € 106,151 | € 56,891 | € 39,944 | ▼ 30% |
| Cash | € 220,755 | € 85,338 | € 136,013 | € 96,614 | ▼ 29% |
| Retained profit | € 60,941 | € 71,090 | € 71,159 | € 45,548 | ▼ 36% |
| Balance sheet total | € 354,243 | € 190,167 | € 140,976 | € 98,418 | ▼ 30% |
Key figures of Children's Tumor Foundation Europe, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Children's Tumor Foundation Europe?
What happened at Children's Tumor Foundation Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Simone MANSO stepped down as director. NBB
- Sissy Marie-Caroline WINDISCH GEB. MULLER stepped down as director. NBB
- Magda CHLEBUS stepped down as director. NBB
- Samia ARSLANE stepped down as director. NBB
- Nikola GAZDOV stepped down as director. NBB
- Sabine MORAVI stepped down as director. NBB
- Stuart Match SUNA stepped down as director. NBB
- Annette BAKKER stepped down as director. NBB
In short
From € 35,225 profit in 2021 to € 25,611 loss in 2024.
Best year ever: 2021, with € 35,225 profit.
A new publication or filing at Children's Tumor Foundation Europe? We notify you, reason included.
Follow Children's Tumor Foundation EuropeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Simone MANSO
Director
since 2019 · until 2030
Sissy Marie-Caroline WINDISCH GEB. MULLER
Director
since 2022 · until 2030
Magda CHLEBUS
Director
since 2019 · until 2030
Samia ARSLANE
Director
since 2022 · until 2030
Nikola GAZDOV
Director
since 2020 · until 2030
Sabine MORAVI
Director
since 2023 · until 2030
Stuart Match SUNA
Director
since 2018 · until 2030
Annette BAKKER
Director
since 2018 · until 2030
Richard HORVITZ
Director
since 2018 · until 2030
Establishments
Establishment units
Physical locations of this company
Sint-Lazaruslaan 4-10 box 6éme
1210 Sint-Joost-ten-Node
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 103 companies are registered at this address.
All companies at this address →Energia
€ 970,536 gross margin · 2025
Aurorium Belgium 2
€ 9.5 million revenue · 2025
HASBRO BELGIUM
€ 658,256 gross margin · 2025
Agra CEAS CONSULTING-Bureau Européen de Recherches
€ 1.5 million gross margin · 2023
BMC Software Belgium
€ 2 million gross margin · 2026
+98 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0711.985.938
- VAT number
- BE 0711.985.938
- Registered office
- Sint-Lazaruslaan 4-10 bus 6éme, 1210 Sint-Joost-ten-Node
- Names & denominations
- Children's Tumor Foundation Europe · CTF Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Public-interest foundation
- Legal situation
- Normale toestand
- Start date
- 23 October 2018
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering